564 related articles for article (PubMed ID: 17718250)
1. Cost-effectiveness analysis of chlorhexidine gluconate compared with povidone-iodine solution for catheter-site care in Siriraj Hospital, Thailand.
Maenthaisong R; Chaiyakunapruk N; Thamlikitkul V
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S94-101. PubMed ID: 17718250
[TBL] [Abstract][Full Text] [Related]
2. Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine.
Chaiyakunapruk N; Veenstra DL; Lipsky BA; Sullivan SD; Saint S
Clin Infect Dis; 2003 Sep; 37(6):764-71. PubMed ID: 12955636
[TBL] [Abstract][Full Text] [Related]
3. Implementation of chlorhexidine gluconate for central venous catheter site care at Siriraj Hospital, Bangkok, Thailand.
Balamongkhon B; Thamlikitkul V
Am J Infect Control; 2007 Nov; 35(9):585-8. PubMed ID: 17980236
[TBL] [Abstract][Full Text] [Related]
4. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis.
Chaiyakunapruk N; Veenstra DL; Lipsky BA; Saint S
Ann Intern Med; 2002 Jun; 136(11):792-801. PubMed ID: 12044127
[TBL] [Abstract][Full Text] [Related]
5. Chlorhexidine-based antiseptic solution vs alcohol-based povidone-iodine for central venous catheter care.
Mimoz O; Villeminey S; Ragot S; Dahyot-Fizelier C; Laksiri L; Petitpas F; Debaene B
Arch Intern Med; 2007 Oct; 167(19):2066-72. PubMed ID: 17954800
[TBL] [Abstract][Full Text] [Related]
6. Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections.
Crawford AG; Fuhr JP; Rao B
Infect Control Hosp Epidemiol; 2004 Aug; 25(8):668-74. PubMed ID: 15357159
[TBL] [Abstract][Full Text] [Related]
7. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients.
Mimoz O; Pieroni L; Lawrence C; Edouard A; Costa Y; Samii K; Brun-Buisson C
Crit Care Med; 1996 Nov; 24(11):1818-23. PubMed ID: 8917031
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 0.05% chlorhexidine and 10% povidone-iodine as cutaneous disinfectant for prevention of central venous catheter-related bloodstream infection: a comparative study.
Ishizuka M; Nagata H; Takagi K; Kubota K
Eur Surg Res; 2009; 43(3):286-90. PubMed ID: 19648751
[TBL] [Abstract][Full Text] [Related]
9. Skin antisepsis for reducing central venous catheter-related infections.
Lai NM; Lai NA; O'Riordan E; Chaiyakunapruk N; Taylor JE; Tan K
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010140. PubMed ID: 27410189
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of 2% chlorhexidine gluconate in 70% alcohol compared with 10% povidone iodine in reducing blood culture contamination in pediatric patients.
Tangsathapompong A; Banjongmanee P; Unrit K; Sritipsukho P; Mungkornkaew N; Sajak S
J Med Assoc Thai; 2014 Aug; 97 Suppl 8():S34-40. PubMed ID: 25518291
[TBL] [Abstract][Full Text] [Related]
11. Alcoholic povidone-iodine or chlorhexidine-based antiseptic for the prevention of central venous catheter-related infections: in-use comparison.
Girard R; Comby C; Jacques D
J Infect Public Health; 2012 Mar; 5(1):35-42. PubMed ID: 22341841
[TBL] [Abstract][Full Text] [Related]
12. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial.
Mimoz O; Lucet JC; Kerforne T; Pascal J; Souweine B; Goudet V; Mercat A; Bouadma L; Lasocki S; Alfandari S; Friggeri A; Wallet F; Allou N; Ruckly S; Balayn D; Lepape A; Timsit JF;
Lancet; 2015 Nov; 386(10008):2069-2077. PubMed ID: 26388532
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection.
Humar A; Ostromecki A; Direnfeld J; Marshall JC; Lazar N; Houston PC; Boiteau P; Conly JM
Clin Infect Dis; 2000 Oct; 31(4):1001-7. PubMed ID: 11049783
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.
Garland JS; Alex CP; Mueller CD; Otten D; Shivpuri C; Harris MC; Naples M; Pellegrini J; Buck RK; McAuliffe TL; Goldmann DA; Maki DG
Pediatrics; 2001 Jun; 107(6):1431-6. PubMed ID: 11389271
[TBL] [Abstract][Full Text] [Related]
15. Combined skin disinfection with chlorhexidine/propanol and aqueous povidone-iodine reduces bacterial colonisation of central venous catheters.
Langgartner J; Linde HJ; Lehn N; Reng M; Schölmerich J; Glück T
Intensive Care Med; 2004 Jun; 30(6):1081-8. PubMed ID: 15085323
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomized trial of 3 antiseptic solutions for prevention of catheter colonization in an intensive care unit for adult patients.
Vallés J; Fernández I; Alcaraz D; Chacón E; Cazorla A; Canals M; Mariscal D; Fontanals D; Morón A
Infect Control Hosp Epidemiol; 2008 Sep; 29(9):847-53. PubMed ID: 18665819
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of chlorhexidine-alcohol versus povidone iodine-alcohol solution in the prevention of intravascular-catheter-related bloodstream infections in France.
Maunoury F; Farinetto C; Ruckly S; Guenezan J; Lucet JC; Lepape A; Pascal J; Souweine B; Mimoz O; Timsit JF
PLoS One; 2018; 13(5):e0197747. PubMed ID: 29799871
[TBL] [Abstract][Full Text] [Related]
18. One percent chlorhexidine-alcohol for preventing central venous catheter-related infection during intensive chemotherapy for patients with haematologic malignancies.
Ohtake S; Takahashi H; Nakagawa M; Uchino Y; Miura K; Iriyama N; Nakayama T; Hatta Y; Takei M
J Infect Chemother; 2018 Jul; 24(7):544-548. PubMed ID: 29627326
[TBL] [Abstract][Full Text] [Related]
19. Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial.
Guenezan J; Marjanovic N; Drugeon B; Neill RO; Liuu E; Roblot F; Palazzo P; Bironneau V; Prevost F; Paul J; Pichon M; Boisson M; Frasca D; Mimoz O;
Lancet Infect Dis; 2021 Jul; 21(7):1038-1048. PubMed ID: 33539734
[TBL] [Abstract][Full Text] [Related]
20. Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates.
Garland JS; Alex CP; Uhing MR; Peterside IE; Rentz A; Harris MC
J Perinatol; 2009 Dec; 29(12):808-13. PubMed ID: 19812587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
